Tumor necrosis factor antagonists in the treatment of multicentric reticulohistiocytosis: Current clinical evidence

Multicentric reticulohistiocytosis (MRH) is a rare and debilitating systemic disorder characterized by cutaneous nodules and destructive polyarthritis. Due to its unknown etiology, the treatment of MRH varies with different rates of success, which causes treatment options to be rather independent an...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHAO, HONGJUN, WU, CHUNMEI, WU, MENGYUN, ZHOU, YAOU, ZHU, HONGLIN, LI, YISHA, YOU, YUNHUI, LUO, HUI, WANG, LIJING, ZUO, XIAOXIA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918541/
https://www.ncbi.nlm.nih.gov/pubmed/27175854
http://dx.doi.org/10.3892/mmr.2016.5253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918541/
https://www.ncbi.nlm.nih.gov/pubmed/27175854
http://dx.doi.org/10.3892/mmr.2016.5253

Ejemplares similares